Cargando…
Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets
BACKGROUND: Significant gaps remain regarding the pathomechanisms underlying the autoimmune response in vitiligo (VL), where the loss of self-tolerance leads to the targeted killing of melanocytes. Specifically, there is incomplete information regarding alterations in the systemic environment that a...
Autores principales: | Dey-Rao, Rama, Sinha, Animesh A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273810/ https://www.ncbi.nlm.nih.gov/pubmed/28129744 http://dx.doi.org/10.1186/s12864-017-3510-3 |
Ejemplares similares
-
In silico Analyses of Skin and Peripheral Blood Transcriptional Data in Cutaneous Lupus Reveals CCR2-A Novel Potential Therapeutic Target
por: Dey-Rao, Rama, et al.
Publicado: (2019) -
Genome-wide gene expression dataset used to identify potential therapeutic targets in androgenetic alopecia
por: Dey-Rao, R., et al.
Publicado: (2017) -
Is targeting circulating T blood cells a therapeutic option for vitiligo?
por: Matos, T.R.
Publicado: (2020) -
Advances in vitiligo: Update on therapeutic targets
por: Feng, Yifei, et al.
Publicado: (2022) -
Six decades of vitiligo genetics: Genomewide studies provide insights into autoimmune pathogenesis
por: Spritz, Richard A.
Publicado: (2011)